We are excited today to bring you a special guest. Jason O’Connor isthe Vice President of Product at Insulet Corp., makers of Omnipod. In hisrole, Jason oversees the development of the innovation pipeline at Insulet.We have no doubt that you, our audience will find this interview to be veryengaging and insightful on the innovation story of Omnipod   The Pod has an IP28 rating for up to 25 feet for 60 minutes.  The PDM/Controller is not waterproof.  The Dexcom G6 Sensor and transmitter are water-resistant and may be submerged under eight feet of water for up to 24 hours without failure when properly installed.  For a list of Omnipod 5 compatible smartphone devices visit Omnipod.com/compatibility

Insulet has sponsored the Pharmacy Podcast Network and it guests, John Hale and Michelle Olbrot to support the creation of this content. This podcast provides general information about health and related subjects.  This information and any other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for medical expertise or treatment.  Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials.  The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution.  .   Approximately 7.4 million Americans with diabetes use one or more formulations of insulin.  For those living with diabetes, the management of the disease is complex and can impact overall quality of life.  This is especially true for those that are utilizing insulin as part of their treatment regimen.  As a vital part of the care team, pharmacists already see patients more than any other healthcare providers and are   reference: https://www.cdc.gov/diabetes/library/reports/reportcard/national-state-diabetes-trends.html [DM1]     reference: https://diabetesjournals.org/care/article/41/6/1299/36487/Insulin-Access-and-Affordability-Working-Group [DM3]    

Disclaimer: Intended audience is the US Healthcare Providers only. These podcasts are not a substitute for medical advice and/or services from a healthcare provider. These podcasts may not be relied upon in any way in connection with your personal health care related decisions and treatment. All such decisions and treatment should be discussed with a healthcare provider who is familiar with your individual needs. Kenneth Snow is Senior Director Medical Affairs. His responsibilities include the development andreview of research studies to provide clinical evidence in support of Insulet’s products.Prior to joining Insulet, Dr. Snow was Product Strategy Medical Director in the Pharmacy ServicesSection of CVS Health and served as Medical Director for Clinical Trial Services overseeing researchprojects for external clients with attention to analytical results and clinical conclusions.Prior to joining CVSHealth, Dr. Snow was Chief Medical Officer for NeuroMetrix, a medical devicecompany involved in the diagnosis and treatment of diabetic neuropathy. Previously, Dr. Snow was onthe staff of the Joslin Diabetes Center in Boston for 19 years including 5 years as Chief of the AdultDiabetes Section. In addition, he was an Assistant Professor of Clinical Medicine at Harvard MedicalSchool.Dr. Snow attended MIT and Johns Hopkins School of Medicine. He did his internship and residency inInternal Medicine at Northwestern Memorial Hospitals in Chicago and his fellowship in Endocrinology atthe New England Medical Center Hospitals in Boston. He received his MBA from the University ofMassachusetts.